![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Oculus Secures FDA Clearance for Post-Dermal Device
Oculus Secures FDA Clearance for Post-Dermal Device
![FDA logo blue](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Blue.gif?t=1614197109&width=430)
Petaluma, Calif.-based Oculus Innovative Sciences has received FDA 510(k) premarket clearance for the company’s post-dermal-procedures device.
The device is intended to remove foreign material and debris after dermal procedures.
Oculus plans to market the device in the U.S. in March 2017. — José Vasquez
Upcoming Events
-
11Jul
-
18Jul
-
21Oct